Navegando por Data de Publicação, começando com "2013-05-03"

Filtrar resultados por ano ou mês

Agora exibindo 1 - 2 de 2

Biorreatores de acetilcolinesterase: estudo de condições para a triagem de ligantes
(Universidade Federal de São Carlos, 2013-05-03) Vanzolini, Kenia Lourenço; Cass, Quezia Bezerra; https://lattes.cnpq.br/9197210255594409; https://lattes.cnpq.br/8140494122257511
The development of ligand screening assays plays a very important role in the discovery of biologically active compounds. In this context, the use of immobilized capillary reactors has been adopted as a new technique for high throughput screening assays, which furnishes high selectivity, reproducibility. This work describes the covalent immobilization of electric fish (Electrophorus electricus) and human acetylcholinesterases (AChE) on fused silica capillaries and magnetic beads. The selected enzyme acts on the central nervous system and is a validated target for the treatment of Alzheimer s disease as for new insecticides. Zonal chromatography with the acetylcholinesterase capillary bioreactors was employed to determine kinetics constants, to a ligand screening assay of 79 compounds, and to inhibition mechanisms determination of the 05 identified ligands. A new approach to the screening of natural product extracts was developed based on ligand fishing experiments and zonal chromatography. For that, the magnetic beads were used for the ligand fishing experiments and capillary bioreactors for the activity assays. The later was employed also under nonlinear condition to determine the affinity constant of the fished ligand. This work reports also the identification by a solution assay of a new acetylcholinesterase substrate and, the studies by zonal bioaffinity chromatography to identify the bi-substrate mechanism.
Papel dos receptores vaniloides TRPV1 da matéria cinzenta periaquedutal na ansiedade e na antinocicepção induzida pelo medo em camundongos
(Universidade Federal de São Carlos, 2013-05-03) Mascarenhas, Diego Cardozo; Souza, Ricardo Luiz Nunes de; https://lattes.cnpq.br/7995624252986295
When confronted with fear situations rodents exhibit behavioral (e.g., fight, flight, immobility and vocalization) and neurovegetative (tachycardia, hypertension and defecation) responses that characterize the defense reactions. In general, these responses are accompanied by antinociception. The exposure of animals to the paradigm of the Elevated Plus Maze (EPM) results in a repertoire of defensive responses and antinociception, since the open arms of the EPM represents a threat to rodents. Several studies have investigated the neural substrate involved in the neurotransmission and neurobiology of aversive situations-induced antinociception, and many have highlighted the involvement of the dorsal portion of periaqueductal gray matter (dPAG). Several mediators which play an important role in modulation of fear/anxiety and nociception states, has been studied and, recently, with the discovery of TRPV1 receptor (Transient Receptor Potential vanilloid type-1), vanilloid compounds, which are agonists of this ion channel, are gaining prominence. It is unclear the role played by these compounds in the modulation of these emotions, since there are some conflicting results in the literature regarding its effects. However, through the use of genetic and pharmacological tools, the vanilloid compounds appear as an interesting target in an attempt to elucidate the neurobiology of pain and anxiety. Thus, the present study aimed to investigate the role of these vanilloid compounds in the modulation of fear/anxiety as well as aversive environment-induced antinociception. Animals were submitted to the agonist capsaicin microinjection intra-dPAG (0, 0.01, 0.1 or 1 nmol) which in the dose of 1 nmol reduced nociception assessed by the formalin test, and increased anxiety assessed by EPM test. Antagonist capsazepine microinjection intra-dPAG (0, 10, 30 or 60 nmol) did not cause any effect on anxiety assessed by EPM. However, the dose of 60 nmol mimicked the capsaicin effects, promoting antinociception assessed by the formalin test, suggesting a tonic role of vanilloids in pain. Interestingly, it was demonstrated the TRPV1 receptor specificity, since mice submitted to capsazepine prior treatment intra-dPAG at dose devoid of effect per se effect (30 nmol) in anxiety and nociception, had the pro-aversive and antinociceptive capsaicin effect completely and selectively reversed. Finally, this same capsazepine dose (30 nmol) was able to attenuate the aversive environment-induced antinociception elicited by the fully open EPM (oEPM: four open arms). Altogether, our results suggest an important role played by the vanilloid compounds in the modulation of defense reactions and antinociception. Also, the pro-aversive and antinociceptive effects of capsaicin are primarily due to selective activation of TRPV1, and finally, the antagonist capsazepine is able to attenuate the oEPM-induced antinociception, a maze derived from the EPM apparatus which elicits more aversion.